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Abstract Dihydroceramide desaturase is responsible for the 
introduction of the 4,5-trans double bond into ceramide. Here, we 
describe the localization of this enzyme in the endoplasmic 
reticulum (ER) using ER- and Golgi-enriched fractions from rat 
liver. Furthermore, enzyme topology was studied. Mild proteo-
lysis of ER-derived vesicles under conditions which assure 
membrane integrity (latency of mannose 6-phosphatase was at 
least 91%) resulted in an up to 90% inactivation of dihydrocer-
amide desaturase activity. This indicates a cytosolic orientation 
of dihydroceramide desaturase activity in the ER membrane. 
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1. Introduction 
Ceramide anchors glycosphingolipids and sphingomyelin in 
the outer leaflet of the plasma membrane. Its physiological 
role is, however, not restricted to this structural function. 
Over the last few years it has become clear that ceramide plays 
important roles in cellular metabolism. It is involved in what 
has become known as the sphingomyelin cycle [1]. It also 
serves as a mediator of cellular apoptosis, differentiation [2], 
and senescence [3], and is involved in the coordination of 
cellular responses to stress situations [4]. 
It was observed that not only ceramide derived from the 
breakdown of sphingomyelin, but also that from de novo syn-
thesis is involved in the cellular responses to inducers of apop-
tosis [5] and differentiation [6]. Taking into consideration that 
dihydroceramide does not mimic the effects of ceramide [7,8], 
it seems possible that dihydroceramide desaturase, the enzyme 
which converts dihydroceramide into ceramide, plays an im-
portant role in the tight regulation of the turnover of ceram-
ide used as a lipid second messenger. 
The de novo synthesis of ceramide starts with the conden-
sation of L-serine and palmitoyl-CoA catalyzed by the pyri-
doxal phosphate dependent serine palmitoyltransferase. Its 
product, 3-dehydrosphinganine, is immediately reduced by 
the NADPH dependent 3-dehydrosphinganine reducíase 
yielding D-erythro-sphinganine [9]. The sequence of the last 
two steps leading to ceramide remained unclear for some 
time, although experimental results strongly favored the for-
mation of dihydroceramide as a biosynthetic intermediate [9-
12]. The discovery of fumonisin Bi as a potent inhibitor of the 
./V-acylation of sphingoid bases [12,13] helped us and others to 
demonstrate that this is, indeed, the case in many cell types 
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[14,15]. Thus, D-ery/Aro-sphinganine is first acylated by the 
sphinganine A^-acyltransferase and ceramide is subsequently 
formed by introduction of a 4,5-trans double bond by the 
NADH dependent dihydroceramide desaturase. 
The first three enzymes involved in sphingolipid biosynthe-
sis are well characterized and were found to be localized in the 
endoplasmic reticulum (ER) membrane with a cytosolic top-
ology [16,17]. We have recently established an in vitro assay 
for dihydroceramide desaturase activity using rat liver micro-
somes as an enzyme source [18]. The aim of the present study 
was to clarify the localization and topology of this enzyme, 
thus filling the 'gap' in the pathway of the de novo synthesis 
of ceramide. 
2. Materials and methods 
2.1. Materials 
Buffers, salts and sucrose were purchased from Merck (Darmstadt, 
Germany). 14C-Labeled fatty acids, detergents, NADH, proteases, 
protease inhibitors, sugar phosphates and other biochemicals were 
of analytical grade and were supplied by Sigma (Munich, Germany). 
X-OMAT Scientific Imaging Film was purchased from Kodak. Male 
Wistar rats (250-300 g) were supplied by Charles River Wiga GmbH 
(Sulzfeld, Germany). 14C-Labeled CMP-N-acetyl neuraminic acid was 
purchased from Amersham (Braunschweig, Germany). The diagnostic 
kit for quantitative determination of inorganic phosphate was sup-
plied by Serva (Heidelberg, Germany). GMla was a kind gift of Fidia 
Research Laboratories (Abano Terme, Italy). 
2.2. Isolation of ER and Golgi vesicles 
Golgi vesicles were isolated from rat liver according to Sandberg et 
al. [19] as described in detail by Yusuf et al. [20,21]. Briefly, rat liver 
was homogenized in 0.3 M sucrose and centrifuged twice at 7500 Xg. 
To the combined supernatants the same volume of 2 M sucrose was 
added. The solution was carefully overlaid with 1.05 M and 0.3 M 
sucrose, respectively, and then centrifuged at 150 000 X g for 2 h. The 
Golgi fraction was recovered from the interface between the 1.05 M 
and 0.3 M sucrose layers. The ER fraction was recovered in the pellet, 
which was resuspended in MOPS-KOH buffer (100 mM, pH 8.0), and 
centrifuged at 105 000 X g for 60 min. The pellet was resuspended in 
MOPS-KOH buffer (100 mM, pH 7.4). Aliquots were frozen in liquid 
nitrogen and stored at —80°C. The Golgi fraction was concentrated 
by centrifugation at 150 000 X g for 45 min on a 1.05 M sucrose layer. 
The band at the interface was carefully saved. Aliquots were frozen in 
liquid nitrogen and stored at —80°C. 
2.3. Protease treatment of ER-derived vesicles 
ER-derived vesicles containing 1 mg of protein were incubated with 
various amounts of either trypsin or pronase (from Streptomyces gri-
seus) for 20 min at 30°C in a final volume of 1 ml of MOPS-KOH 
buffer (100 mM, pH 7.4). Disruption of ER-derived vesicles was per-
formed by incubation at 4°C for 15 min in the presence of CHAPS in 
a final concentration of 0.5% (w/v) prior to protease treatment. Pro-
nase digestion also included 0.5 mM CaCl2. The reactions were ter-
minated by diluting the samples 9-fold with ice-cold MOPS-KOH 
buffer containing 1 mM phenylmethylsulfonyl fluoride, 1 Ug/ml leu-
peptin and 5 mM EDTA. After centrifugation at 105 000 X g for 60 
min the pellet was suspended in 200 ul of the same buffer. 
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Table 1 
Localization of glucose 6-phosphatase, GDla synthase (sialyltransferase IV) and dihydroceramide desaturase in ER- and Golgi-derived vesicles 
Glucose 6-phosphatase 
GDla synthase (sialyltransferase IV) 
Dihydroceramide desaturase 
Protein per fraction (mg) 
Specific activity (nmol/min/mg) 
Total activity (nmol/min) 
Relative total activity (%) 
Specific activity (pmol/min/mg) 
Total activity (pmol/min) 
Relative total activity (%) 
Specific activity (pmol/min/mg) 
Total activity (nmol/min) 
Relative total activity (%) 
ER fraction 
106 ±10 
17.2 
1823 
98.7 
1.1 
116.6 
32.3 
885 
93.8 
99.3 
Golgi fraction 
2.5 ±0.8 
9.6 
24 
1.3 
74.1 
244.5 
67.7 
252 
0.6 
0.7 
Rat liver was fractionated into vesicles derived from ER and Golgi according to the procedure described in Section 2. Total activities were 
calculated by multiplying the specific enzymatic activity of each fraction by the milligrams of protein recovered from each fraction. The latency 
of mannose 6-phosphatase of ER-derived vesicles was at least 93%. The vesicles were enriched 6.8-fold over homogenate in glucose 6-phosphatase 
activity and 1-fold in GDla synthase activity. Golgi vesicles were enriched 1.2-fold over homogenate in glucose 6-phosphatase activity and 34.5-fold 
in GDla synthase activity. 
2.4. Assays of enzymatic activities 
Dihydroceramide desaturase activity was determined as described 
recently [18]. Briefly, 100 ug of protein, 15 nmol Ar-[l-14C]octanoyl-D-
eryi/iro-sphinganine (as complex with 2 equivalents of bovine serum 
albumin) and 1 mM NADH were incubated in 330 ul MOPS-KOH 
buffer (100 mM, pH 7.4) at 37°C for 60 min. The reaction was termi-
nated by addition of chloroform/methanol. After extraction, the lipids 
were separated by TLC, visualized by autoradiography and quanti-
tated by densitometry. 
Glucose 6-phosphatase activity (marker enzyme for ER fraction) 
[22] and GDla synthase activity (sialyltransferase IV; marker enzyme 
for Golgi fraction) [23] were measured according to previously de-
scribed methods. 
The integrity of ER vesicles was examined by measuring the latency 
of mannose 6-phosphatase [22]. 
Contamination of ER- and Golgi-derived vesicles with other cellu-
lar membranes was determined by measuring 5'-nucleotidase activity 
(marker enzyme for plasma membrane fraction) and acid phosphatase 
activity (marker enzyme for lysosomal fraction) as previously de-
scribed [22]. 
2.5. Miscellaneous procedures 
A^l-^qOctanoyl-D-eryiAro-sphinganine was prepared as described 
[18]. Protein was determined by the method of Bradford [24] using 
bovine serum albumin as standard protein. 
2.6. Presentation of data 
All data presented are means of three separate experiments. At least 
double determinations were performed in each experiment. All indi-
vidual values were in the range of ± 12% of the mean. 
3. Results and discussion 
3.1. Subcellular distribution of dihydroceramide desaturase 
The fraction of ER-derived vesicles used in this study was 
enriched 6.8-fold over homogenate in glucose 6-phosphatase 
activity and 1-fold in G D l a synthase activity. Golgi vesicles 
were enriched 1.2-fold over homogenate in glucose 6-phospha-
tase activity and 34.5-fold in G D l a synthase activity. This 
method of separation of the Golgi compartment from E R 
membranes yielded good results, as can be concluded from 
the specific and total activities of both marker enzymes (Table 
1). About 70% of total G D l a synthase activity was found 
in the Golgi fraction, whereas the glucose 6-phosphatase 
activity was almost quantitatively recovered in the ER frac-
tion. 
Contaminat ion with plasma membrane and lysosomes was 
assessed by measuring the enrichment of 5'-núcleotidase and 
acid phosphatase activity over the respective homogenate ac-
tivity in the fractions. ER-derived membranes showed a 3.3-
fold 5'-nucleotidase and a 1.9-fold acid phosphatase enrich-
ment. For Golgi vesicles, the enrichment was found to be 2.7-
fold and 1-fold, respectively. 
Based on the latency of glucose 6-phosphatase towards 
mannose 6-phosphate [22], a substrate which cannot be trans-
ported across the liver ER membrane [25], at least 9 3 % of the 
Table 2 
Effects of protease treatment on dihydroceramide desaturase activity in intact and disrupted ER-derived vesicles from rat liver 
Protease 
Trypsin 
(ug/mg protein) 
0 
50 
100 
300 
0 
25 
50 
100 
Dihydroceramide desaturase activity 
In disrupted vesicles 
specific 
(nmol/h/mg) 
18.6 
9.5 
5.5 
3.9 
20.5 
6.7 
3.7 
1.2 
relative 
(%) 
100 
51.1 
29.6 
21.0 
100 
32.7 
18.0 
5.9 
In intact vesicles 
specific 
(nmol/h/mg) 
22.5 
10.7 
7.8 
5.5 
25.0 
8.7 
5.3 
2.1 
relative 
(%) 
100 
47.6 
34.7 
24.4 
100 
34.8 
21.2 
8.4 
Pronase 
ER-derived vesicles were incubated with either trypsin or pronase as described in Section 2. The latency of mannose 6-phosphatase of intact ER-
derived vesicles remained unchanged after proteolysis (92 ± 2%), but was susceptible to both proteases in disrupted vesicles. Disruption of vesicles 
was achieved by treatment with 0.5% CHAPS (w/v) as described in Section 2. Addition of the dihydroceramide desaturase assay components to 
intact vesicles did not alter the membrane integrity (mannose 6-phosphatase latency was 91 ±2%). 
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ER-derived vesicles were sealed and of the correct mem-
brane topology ('right side out') after the preparation proce-
dure. 
As shown in Table 1, dihydroceramide desaturase activity 
was almost quantitatively (>99%) recovered in the ER-de-
rived vesicles. Furthermore, its distribution among the two 
membrane fractions was paralleled by that of the ER marker 
enzyme, glucose 6-phosphatase. Therefore, our results 
strongly suggest that dihydroceramide desaturase is located 
in the endoplasmic reticulum. 
3.2. Topology of dihydroceramide desaturase 
Mild proteolysis of ER-derived vesicles with various 
amounts of trypsin or pronase in either the presence or ab-
sence of detergent (CHAPS) led to a concentration dependent 
reduction of dihydroceramide desaturase activity (Table 2). 
This result was not due to disturbance of membrane integrity, 
since in the absence of detergent the latency of mannose 6-
phosphatase remained unaltered after treatment with pro-
teases (92% latency). Subsequent addition of all dihydrocera-
mide desaturase assay components (bovine serum albumin, N-
[l-14C]octanoyl-D-er^/*r0-sphinganine and NADH) did not 
affect the latency of mannose 6-phosphatase either (91% la-
tency). Only in the presence of CHAPS was mannose 6-phos-
phatase susceptible to proteolysis, as was shown before [26]. 
These findings strongly suggest a cytosolic orientation of the 
dihydroceramide desaturase activity. 
The antiluminal topology of this enzyme is not unexpected, 
since we showed recently that dihydroceramide desaturase 
appears to be part of the ER resident cytochrome ¿5 electron 
transport system [18], which is also localized in the cytosolic 
leaflet. Moreover, all known fatty acyl CoA desaturases re-
ceive the required electrons from this system and share the 
same cytosolic topology in the ER [27]. Furthermore, dihy-
droceramide, the substrate for dihydroceramide desaturase, is 
likewise synthesized on the cytosolic face of the ER [16] and 
would, therefore, be directly accessible to the active site of this 
enzyme. 
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